FibroGen (FGEN) - Hot FDA News

FibroGen (FGEN) – Hot FDA News

Jun 26, 2023 07:04 AM FibroGen (FGEN) Phase 3 ZEPHYRUS-1 Study of Pamrevlumab for Treatment of Idiopathic Pulmonary Fibrosis Did Not Meet Primary Endpoint
Jun 7, 2023 07:26 AM FibroGen (FGEN) Declines 7% After LELANTOS-1 Phase 3 Clinical Study of Pamrevlumab in Non-Ambulatory Patients with DMD Misses Primary Endpoint
May 5, 2023 07:32 AM
Aug 25, 2021 07:01 AM
Aug 11, 2021 07:00 AM
Jul 15, 2021 06:34 PM
Apr 15, 2021 07:04 AM
Apr 12, 2021 07:00 AM
Apr 6, 2021 04:04 PM
Mar 1, 2021 04:06 PM
Nov 8, 2019 02:09 PM
Nov 8, 2019 02:03 PM
May 9, 2019 04:45 PM
Oct 18, 2017 07:06 AM
Sep 13, 2017 07:04 AM
Jun 5, 2017 07:12 AM